Skip to main content

Lupus

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
      Rheumatology Round-Up with Drs. Kavanaugh & Cush

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

      Lifestyle and Risk of RA, Lupus: Dr. Janet Pope

      Dr. Janet Pope reviews abstracts #1198 and #1473 presented at the 2020 ACR annual meeting.

      Pregnancy Outcomes in Lupus and SpA: Dr. Kathryn Dao

      Dr. Dao reviews abstracts #1770, #1771 and #1762 presented at the 2020 ACR annual meeting. 

      RT @MeralElRamahiMD: Summary of #ACR20 part B:
      - The future is bright with many trainees producing great research per Dr
      Summary of #ACR20 part B: - The future is bright with many trainees producing great research per Dr. Diane Karen - Belimumab (phase III) reduced proteinuria, improved renal for, and helped w/ tapering of GC in pts w/ lupus nephritis but more infect in GC group @RheumNow
      RT @ejdein1: #ACR20 imaging competition: 27 yo F with h/o SLE nephritis s/p kidney transplant p/w abdominal pain due to
      4 years ago
      #ACR20 imaging competition: 27 yo F with h/o SLE nephritis s/p kidney transplant p/w abdominal pain due to abdominal wall tophus @RheumNow. https://t.co/iDlF3neIYM
      Pregnancy in SLE is a high risk situation and active disease can lead to fetal loss, pre-term birth, IUGR and neonatal lupus syndromes. Therefore, we counsel our patients that pregnancy should be…
      Belimumab in Lupus Nephritis: Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1441 presented at the 2020 ACR annual meeting.

      RT @ACRheum: With Phase 2 of the Accelerating Medicines Partnership study of SLE underway, an #ACR20 session featured a
      With Phase 2 of the Accelerating Medicines Partnership study of SLE underway, an #ACR20 session featured a panel that reviewed the methods being used to generate data & discussed some of the findings. Read the recap → https://t.co/hTnCdfBn10